AAAAAA
Results:
1-8
|
Results: 8
Authors:
Thibodeau, PA
Kocsis-Bedard, S
Courteau, J
Niyonsenga, T
Paquette, B
Citation: Pa. Thibodeau et al., Thiols can either enhance or suppress DNA damage induction by catecholestrogens, FREE RAD B, 30(1), 2001, pp. 62-73
Authors:
De Wals, P
De Serres, G
Niyonsenga, T
Citation: P. De Wals et al., Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec, J AM MED A, 285(2), 2001, pp. 177-181
Authors:
Berard, A
Andreu, N
Tetrault, JP
Niyonsenga, T
Myhal, D
Citation: A. Berard et al., Reliability of Chalmers' scale to assess quality in meta-analyses on pharmacological treatments for osteoporosis, ANN EPIDEMI, 10(8), 2000, pp. 498-503
Authors:
Xhignesse, M
Laplante, P
Niyonsenga, T
Courteau, J
Grant, AM
Citation: M. Xhignesse et al., Dyslipidemias and the primary prevention of cardiovascular disease: Analysis of the FAMUS primary care register, CAN J CARD, 16(7), 2000, pp. 879-885
Authors:
Lussier-Cacan, S
Bolduc, A
Xhignesse, M
Niyonsenga, T
Connelly, PW
Sing, CF
Citation: S. Lussier-cacan et al., Impact of age and body size on inter-individual variation in measures of lipid metabolism: influence of gender and apolipoprotein E genotype, CLIN GENET, 57(1), 2000, pp. 35-47
Authors:
Renolleau, S
Letourneau, P
Niyonsenga, T
Praud, JP
Gagne, B
Citation: S. Renolleau et al., Thyroarytenoid muscle electrical activity during spontaneous apneas in preterm lambs, AM J R CRIT, 159(5), 1999, pp. 1396-1404
Authors:
Xhignesse, M
Laplante, P
Grant, AM
Niyonsenga, T
Delisle, E
Vanasse, N
Bernier, R
Citation: M. Xhignesse et al., Antiplatelet and lipid-lowering therapies for the secondary prevention of cardiovascular disease: Are we doing enough?, CAN J CARD, 15(2), 1999, pp. 185-189
Authors:
Niyonsenga, T
De Wals, P
Citation: T. Niyonsenga et P. De Wals, A method for the follow-up of clusters of adverse reproductive outcomes, EUR J EPID, 15(9), 1999, pp. 833-837
Risultati:
1-8
|